Holen Sie sich die Stockscreener-App
635.66
0.78%
4.93
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$630.73
Offen:
$626.75
24-Stunden-Volumen:
301.66K
Relative Volume:
0.57
Marktkapitalisierung:
$50.76B
Einnahmen:
$4.30B
Nettoeinkommen (Verlust:
$1.06B
KGV:
48.61
EPS:
13.076
Netto-Cashflow:
$1.04B
1W Leistung:
+1.00%
1M Leistung:
-7.34%
6M Leistung:
-0.65%
1J Leistung:
+40.37%
1-Tages-Spanne:
$625.22
$638.14
1-Wochen-Bereich:
$623.28
$639.28
52-Wochen-Spanne:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
635.66 | 50.36B | 4.30B | 1.06B | 1.04B | 13.08 |
|
TMO
Thermo Fisher Scientific Inc
|
510.93 | 193.53B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
209.50 | 149.33B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
A
Agilent Technologies Inc
|
122.90 | 35.73B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
333.33 | 32.24B | 3.17B | 642.63M | 539.81M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Raiffeisen Bank International AG Has $35.07 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
Quarterly Recap: Can IDEXX Laboratories Inc keep up with sector leaders2025 Biggest Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Idexx Laboratories: A New Opportunity in Pet Health Investment - Intellectia AI
Sophie V Vandebroek At IDEXX Laboratories Decides to Exercises Options Worth $273K - Benzinga
Here’s Why IDEXX Laboratories (IDXX) Shares are Re-Rating to Historical Average - Insider Monkey
Are Wall Street Analysts Bullish on IDEXX Laboratories Stock? - inkl
HighTower Advisors LLC Cuts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by Factory Mutual Insurance Co. - Defense World
Fiera Capital Corp Has $83.39 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - Defense World
Will IDEXX Laboratories Inc. announce a stock splitBull Run & Weekly Watchlist for Hot Stocks - mfd.ru
Idexx Labs director Vandebroek sells $920k in shares By Investing.com - Investing.com South Africa
Idexx Labs director Vandebroek sells $920k in shares - Investing.com
IDEXX Laboratories (NASDAQ:IDXX) EVP Sells $3,369,657.98 in Stock - MarketBeat
Sophie Vandebroek Sells 1,464 Shares of IDEXX Laboratories (NASDAQ:IDXX) Stock - MarketBeat
IDEXX Stock Has Rallied 40% Over the Past Year: Can a New CEO Keep the Momentum Going? - TIKR.com
JPMorgan Chase & Co. Buys 326,348 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
NEOS Investment Management LLC Grows Holdings in IDEXX Laboratories, Inc. $IDXX - Defense World
Marble Harbor Investment Counsel LLC Reduces Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Fifth Third Bancorp Buys 1,392 Shares of IDEXX Laboratories, Inc. $IDXX - Defense World
Vanguard Group Inc. Boosts Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Glenview Trust Co Increases Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Veterinary Reference Laboratory Market Size to Reach USD 13.93 Billion by 2035 with 8.58% CAGR – SNS Insider - GlobeNewswire Inc.
IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Exploring A 19.21% Upside Potential - DirectorsTalk Interviews
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors - Yahoo Finance
IDEXX Laboratories, Inc. $IDXX is TimesSquare Capital Management LLC's 6th Largest Position - MarketBeat
IDEXX Laboratories Inc. (IDXX) Shows Resilience as Analysts Reassess Targets - Bitget
10 Best Medical Technology Stocks to Invest In - Insider Monkey
Assetmark Inc. Has $32.74 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (IDXX) Announces Board Changes Ahead of 2026 Annual Meeting - GuruFocus
Idexx Laboratories Announces Director Retirement and Board Changes - TipRanks
Idexx Labs exec Fennell sells $7.3m in shares - Investing.com
Agree To Purchase Idexx Laboratories At $560, Earn 8.5% Annualized Using Options - Nasdaq
Wealthfront Advisers LLC Buys 2,463 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories to Present at Two Institutional Investor Conferences - 01net
4,049 Shares in IDEXX Laboratories, Inc. $IDXX Purchased by Krilogy Financial LLC - MarketBeat
Rhumbline Advisers Reduces Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Caprock Group LLC Invests $5 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$7.34 Million in Common Stock - 富途牛牛
Insider Selling: IDEXX Laboratories (NASDAQ:IDXX) EVP Sells 11,345 Shares of Stock - MarketBeat
Baron Partners Fund is Leveraging IDEXX Laboratories’ (IDXX) Long-Term Growth Drivers - Insider Monkey
IDEXX Laboratories, Inc. $IDXX Shares Sold by Jensen Investment Management Inc. - MarketBeat
Midwest Trust Co Purchases 12,179 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Stock Position Decreased by RFG Advisory LLC - MarketBeat
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
Aug Swings: Can IDEXX Laboratories Inc keep up with sector leadersJuly 2025 Breakouts & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
IDEXX Laboratories, Inc. $IDXX Shares Sold by ProShare Advisors LLC - MarketBeat
Candriam S.C.A. Has $14.68 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $750 - 富途牛牛
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating - marketscreener.com
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Examining the 16.39% Potential Upside for Savvy Investors - DirectorsTalk Interviews
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.72%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):